WALL STREET ASSOCIATES - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 50 filers reported holding NIVALIS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,385,000
+76.7%
170,4000.0%0.47%
+50.3%
Q2 2016$784,000
+10.3%
170,4000.0%0.31%
+6.4%
Q1 2016$711,000
-46.1%
170,4000.0%0.30%
-20.5%
Q4 2015$1,319,000
-40.3%
170,4000.0%0.37%
-12.3%
Q3 2015$2,210,000
-24.2%
170,400
-11.4%
0.42%
+53.8%
Q2 2015$2,915,000192,4000.28%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
BVF INC/IL 1,195,013$9,249,0001.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$28,889,0001.17%
TIGER MANAGEMENT L.L.C. 650,915$5,038,0000.65%
RA Capital Management 612,863$4,744,0000.47%
WALL STREET ASSOCIATES 170,400$1,319,0000.37%
Rock Springs Capital Management LP 489,000$3,785,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 231,548$1,792,0000.26%
SABBY MANAGEMENT, LLC 503,595$3,898,0000.21%
KINGDON CAPITAL MANAGEMENT, L.L.C. 399,663$3,093,0000.15%
DAFNA Capital Management LLC 15,000$116,0000.10%
View complete list of NIVALIS THERAPEUTICS INC shareholders